Parasite | Eso | Sto | Cancer | ESD
001 | 101 | 201 | 301 | 401 | 501 | 601 | 701 | 801 | 901 | 1000
°ËÁø ³»½Ã°æ¿¡¼ ¹ß°ßµÈ AGCÀÔ´Ï´Ù. MassÀÇ ÀϺΰ¡ ÇÔ¸ôµÇ¾úÁö¸¸ ±×·¡µµ ÀüüÀûÀ¸·Î´Â À¶±âµÈ ¸ð¾çÀ¸·Î AGC Borrmann type IÀ¸·Î Áø´ÜÇÏ¿´½À´Ï´Ù. Á¶Á÷°Ë»ç´Â tubular adenocarcinoma, moderately differentiated with neuroendocrine differentiationÀ¸·Î º¸°íµÇ¾ú½À´Ï´Ù.
Stomach, subtotal gastrectomy: Advanced gastric carcinoma
1. Location : lower third, Center at antrum and lesser curvature
2. Gross type : Borrmann type 2
3. Histologic type : tubular adenocarcinoma, moderately differentiated with focal neuroendocrine differentiation
4. Histologic type by Lauren : intestinal
5. Size : 3.5x4.5 cm
6. Depth of invasion : penetrates subserosal connective tissue (pT3)
7. Resection margin: free from carcinoma, safety margin: proximal 4.5 cm, distal 4 cm
8. Lymph node metastasis : metastasis to 5 out of 52 regional lymph nodes (pN2) (perinodal extension: present) (5/52: "3", 2/17; "4", 1/14; "5", 1/2; "6", 0/4; "7", 0/2; "8a", 0/2; "9", 0/1; "11p", 0/2; "12a", 1/3; "4sb", 0/4; "1", 0/0; "4d", 0/1)
9. Lymphatic invasion : not identified
10. Venous invasion : not identified
11. Perineural invasion : not identified
12. Associated findings : ulceration
13. Peritoneal cytology : negative
14. AJCC stage by 7th edition: pT3 N2
Áõ·Ê¿Í °ü·ÃÇÏ¿© 3°¡Áö Á¤µµÀÇ »ý°¢ÇØ º¸¾Ò½À´Ï´Ù.
+++ 1 +++
³»½Ã°æ ÀÇ»ç´Â º¸¸¸ 1ÇüÀ¸·Î ÁÖ¾ú´Âµ¥ º´¸®ÀÇ»ç´Â º¸¸¸ 2ÇüÀ¸·Î ÁÖ¾ú½À´Ï´Ù. ÈçÈ÷ ÀÖ´Â ÀÏÀÔ´Ï´Ù. ¾à°£ ±Ë¾çÀÌ ÀÖ´Â °ÍÀº »ç½ÇÀ̴ϱî... º¸Åë ºñ±³Àû µÕ±×·¸°í ±Ë¾çÀÌ ±í°í ±Ë¾ç ÁÖº¯ÀÇ damÀÌ µÎ²®Áö ¾Ê°í ÇöÀúÈ÷ À¶±âµÇ¾î ÀÖÀ¸¸é º¸¸¸ 2ÇüÀ̶ó°í ºÎ¸£°í ÀÖ½À´Ï´Ù. ±×³É µ¢¾î¸®ÀÌ°í Áß¾ÓÀÌ ¾à°£ ÇÔ¸ôµÇ¾î ÀÖÀ¸¸é º¸¸¸ 1ÇüÀ¸·Î ºÎ¸¨´Ï´Ù. ÁÖ°üÀûÀÔ´Ï´Ù.
+++ 2 +++
Forceps biopsy¿Í surgical pathology¿¡¼ ¸ðµÎ focal neuroendocrine differentiationÀÇ ¾ð±ÞÀÌ ÀÖ½À´Ï´Ù. ÀϹÝÀûÀÎ adenocarcinoma (ÀÌ´Â exocrine tumor¶ó°í ÇÒ ¼ö ÀÖ½À´Ï´Ù. Gastric epithelium¿¡¼ ¹ß»ýÇÏ´Â tumorÀ̱⠶§¹®ÀÔ´Ï´Ù)¿¡ ¾à°£ÀÇ endocrine component°¡ µ¿¹ÝµÈ °æ¿ì´Â °£È¤ ÀÖ½À´Ï´Ù. Ä¡·á´Â ¶È°°½À´Ï´Ù.
±×·¯³ª exocrine component¿Í endoscrine component°¡ ´ëµîÇϸé amphicrine tumor¶ó°í ÇÕ´Ï´Ù. ±âÁØÀº »ó´çÈ÷ ÀÛÀ§ÀûÀÌÁö¸¸ ´ë° 30%·Î Àâ°í ÀÖ½À´Ï´Ù. ÃÖ±Ù¿¡´Â Mixed Adenoneuroendocrine Carcinomas (MANECs)¶ó´Â À̸§À¸·Î ÅëÀϵǰí ÀÖ´Â °Í °°½À´Ï´Ù (Cancers 2012;4:11-30).
Amphicrine tumorÀÇ Æ¯Â¡Àº ¾Æ·¡°ú °°½À´Ï´Ù.
+++ 3 +++
12a ¸²ÇÁÀý ÀüÀÌ°¡ ÀÖ¾ú½À´Ï´Ù. Left hepatoduodenal nodeÀÔ´Ï´Ù. ÀÌ´Â °ú°Å ¹æ½ÄÀ¸·Î´Â group 2 stationÀÔ´Ï´Ù. À§¾ÏÀÌ mid 1/3 ȤÀº distal 1/3¿¡¼´Â group 2·Î proximal 1/3¿¡¼´Â group 3·Î ºÒ·¶½À´Ï´Ù.
© ÀÏ¿ø³»½Ã°æ±³½Ç ¹Ù¸¥³»½Ã°æ¿¬±¸¼Ò ÀÌÁØÇà. EndoTODAY Endoscopy Learning Center. Lee Jun Haeng.